The synthesis and characterization of a series of nickel, palladium, and platinum complexes containing new achiral and chiral PCP pincer ligands based on 1,3-diaminobenzene, 5-trifluoromethyl-1,3-diaminobenzene, and 3,5-diamino-4-chloroisobutylbenzoate are reported. The new PCP ligands are prepared conveniently in high yield by treatment of the respective diaminobenzene with 2 equiv of a variety of achiral and chiral R 2 PCl compounds in the presence of base. PCP complexes of Ni(II), Ni(PCP)Cl, were synthesized by the reaction of NiCl 2 ·6H 2 O with 1 equiv of a PCP ligand. In similar fashion, treatment of M(COD)X 2 (M = Pd, Pt; X = Cl, Br) with 1 equiv of a PCP ligand yields the square-planar complexes M(PCP)X. Palladium PCP complexes featuring a coordinated TFA ligand (TFA = CF 3 COO - ) are obtained by the reaction of Pd(TFA) 2 with 1 equiv of a PCP ligand. Alternatively, palladium PCP complexes can also be generated via an oxidative addition route. Addition of 2 equiv of PCP ligands based on 3,5-diamino-4-chloroisobutylbenzoate to Pd 2 (dba) 3 affords the respective Pd(PCP)Cl pincer complexes in high yields. X-ray structures of representative Ni, Pd, and Pt PCP complexes have been determined. Finally, the use of the palladium complexes as catalysts for the Suzuki−Miyaura coupling of some aryl bromides and phenyl boronic acid has been examined.
No takes yet. Share an insight, caveat, or question.
Benito‐Garagorri et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: